Publication | Open Access
First evidence of significant clinical activity of PD-1 inhibitors in metastatic, castration resistant prostate cancer (mCRPC)
30
Citations
0
References
2016
Year
UrologyOncologyGenitourinary CancerFirst EvidenceMedicinePd-1 InhibitorsPharmacotherapySignificant Clinical ActivityCancer TreatmentProstatic DiseasePharmacologyMolecular Oncology
No additional data available for this publication yet. Check back later!